SE0302559D0 - Method - Google Patents

Method

Info

Publication number
SE0302559D0
SE0302559D0 SE0302559A SE0302559A SE0302559D0 SE 0302559 D0 SE0302559 D0 SE 0302559D0 SE 0302559 A SE0302559 A SE 0302559A SE 0302559 A SE0302559 A SE 0302559A SE 0302559 D0 SE0302559 D0 SE 0302559D0
Authority
SE
Sweden
Prior art keywords
methods
specific drug
disease
mmp12
copd
Prior art date
Application number
SE0302559A
Other languages
English (en)
Swedish (sv)
Inventor
Thomas Fehniger
Gyoergy Marko-Varga
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302559A priority Critical patent/SE0302559D0/xx
Publication of SE0302559D0 publication Critical patent/SE0302559D0/xx
Priority to ES04775479T priority patent/ES2303954T3/es
Priority to PCT/SE2004/001378 priority patent/WO2005029090A1/en
Priority to US10/572,872 priority patent/US8012692B2/en
Priority to EP04775479A priority patent/EP1668372B1/de
Priority to AT04775479T priority patent/ATE393395T1/de
Priority to DE602004013350T priority patent/DE602004013350T2/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SE0302559A 2003-09-25 2003-09-25 Method SE0302559D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0302559A SE0302559D0 (sv) 2003-09-25 2003-09-25 Method
ES04775479T ES2303954T3 (es) 2003-09-25 2004-09-24 Huellas peptidicas de elastina y metodos de analisis para mmp12 relacionadas con copd.
PCT/SE2004/001378 WO2005029090A1 (en) 2003-09-25 2004-09-24 Elastin peptide fingerprints and analysis methods for mmp12 related to copd
US10/572,872 US8012692B2 (en) 2003-09-25 2004-09-24 Elastin peptide fingerprints and analysis methods for MMP12 related to COPD
EP04775479A EP1668372B1 (de) 2003-09-25 2004-09-24 Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12
AT04775479T ATE393395T1 (de) 2003-09-25 2004-09-24 Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12
DE602004013350T DE602004013350T2 (de) 2003-09-25 2004-09-24 Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302559A SE0302559D0 (sv) 2003-09-25 2003-09-25 Method

Publications (1)

Publication Number Publication Date
SE0302559D0 true SE0302559D0 (sv) 2003-09-25

Family

ID=29246968

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302559A SE0302559D0 (sv) 2003-09-25 2003-09-25 Method

Country Status (7)

Country Link
US (1) US8012692B2 (de)
EP (1) EP1668372B1 (de)
AT (1) ATE393395T1 (de)
DE (1) DE602004013350T2 (de)
ES (1) ES2303954T3 (de)
SE (1) SE0302559D0 (de)
WO (1) WO2005029090A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100203565A1 (en) * 2005-03-22 2010-08-12 Astrazeneca Ab Peptide Fingerprint from the Degradation of Elastin by HNE
US8673267B2 (en) 2009-03-02 2014-03-18 Massachusetts Institute Of Technology Methods and products for in vivo enzyme profiling
JP6245990B2 (ja) 2011-03-15 2017-12-13 マサチューセッツ インスティテュート オブ テクノロジー 同位体によりコード化されたレポーターによる多重検出
MX2015014053A (es) * 2013-04-05 2016-04-07 Claudia Zylberberg Metaloproteinasas de matriz y sus usos.
JP6847660B2 (ja) 2013-06-07 2021-03-24 マサチューセッツ インスティテュート オブ テクノロジー リガンドをコードする合成バイオマーカーのアフィニティベースの検出
CN105527361B (zh) * 2014-09-29 2017-06-20 上海市计算技术研究所 一种高效微流电色谱相似度分析以及计算影响度的方法
EP3440013A4 (de) 2016-04-08 2021-03-17 Massachusetts Institute of Technology Verfahren zur spezifischen profilierung der protease-aktivität an lymphknoten
WO2017193070A1 (en) 2016-05-05 2017-11-09 Massachusetts Institute Of Technology Methods and uses for remotely triggered protease activity measurements
CA3059358A1 (en) 2017-04-07 2018-10-11 Massachusetts Institute Of Technology Methods to spatially profile protease activity in tissue and sections
GB201802070D0 (en) * 2018-02-08 2018-03-28 Nordic Bioscience As Elastin assay
WO2019173332A1 (en) 2018-03-05 2019-09-12 Massachusetts Institute Of Technology Inhalable nanosensors with volatile reporters and uses thereof
CN108872442B (zh) * 2018-08-17 2021-04-27 无限极（中国）有限公司 一种基于谱效关系的骨胶原肽质量检测方法
US12173349B2 (en) 2018-09-25 2024-12-24 Massachusetts Institute Of Technology Lung protease nanosensors and uses thereof
US11835522B2 (en) 2019-01-17 2023-12-05 Massachusetts Institute Of Technology Sensors for detecting and imaging of cancer metastasis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2311688A (en) * 1987-08-07 1989-03-09 Graduate Hospital Foundation Research Corporation Immunologic identification of carboxy terminal sequences of elastin in human plasma using monospecific antibodies
US6124107A (en) * 1988-06-10 2000-09-26 Merck & Co., Inc. Assay for marker of human polymorphonuclear leukocyte elastase activity
WO1991018290A1 (en) * 1990-05-11 1991-11-28 Graduate Hospital Foundation Research Corporation Immunoassay of elastin peptides in urine
WO1999064626A2 (en) 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
US6797523B2 (en) * 2000-11-30 2004-09-28 Affinium Pharmaceuticals, Inc. Methods for systematic identification of protein—protein interactions
EP1366175B1 (de) 2000-12-18 2008-01-23 Arriva Pharmaceuticals, Inc. Multifunktionelle protease-inhibitoren und deren verwendung zur behandlung von krankheiten

Also Published As

Publication number Publication date
ATE393395T1 (de) 2008-05-15
US8012692B2 (en) 2011-09-06
ES2303954T3 (es) 2008-09-01
DE602004013350D1 (de) 2008-06-05
EP1668372A1 (de) 2006-06-14
WO2005029090A1 (en) 2005-03-31
EP1668372B1 (de) 2008-04-23
DE602004013350T2 (de) 2009-05-20
US20060292631A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
SE0302559D0 (sv) Method
WO2003000842A3 (en) Novel proteins and nucleic acids encoding same
DE60224291D1 (de) System zur antikörperexpression und- synthese
EA200700136A1 (ru) Анти-cd154-антитела
ATE488586T1 (de) In vitro peptid-expressionsbank
GB2490404B (en) Methods for determining ligand binding to a target protein using a thermal shift assay
NZ591415A (en) Haemophilus influenzae type B
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
ATE528396T1 (de) Look-through-mutagenese zur entwicklung veränderter polypeptide mit verbesserten eigenschaften
WO2020198264A8 (en) Modified cleavases, uses thereof and related kits
JP2019507341A5 (de)
WO2011010304A3 (en) Method for preparing molecularly imprinted polymers and uses thereof
WO2004024750A3 (en) Cd44-binding ligands
CN108033995B (zh) 两种来源于大黄鱼肌联蛋白的ace抑制肽
JP2016537981A5 (de)
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
WO2002081498A3 (en) Novel proteins and nucleic acids encoding same
WO2006062402A3 (en) Heat shock proteins (hsp) and supraventricular arrhythmia
WO2009074318A3 (en) Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
WO2004094476A3 (en) Compositions and methods relating to stop-1
WO2004042083A3 (en) Nucleic acid ligands and uses therefor
WO2007039256A3 (de) Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
WO2005042006A3 (en) Use of ephrins and related molecules to regulate cellular proliferation
WO2003073351A3 (en) Screening process